Comparison of the effects of chronic intermittent hypobaric hypoxia and continuous hypobaric hypoxia on hemodynamics in rats. 2008

Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
Department of Physiology, Hebei Medical University, Shijiazhuang, China.

The aim of this study is to investigate the effects of chronic intermittent hypobaric hypoxia (IHH) and chronic continuous hypobaric hypoxia (CHH) on hemodynamics under basic normoxia and acute hypoxia conditions and to find the difference of two types of chronic hypoxia. Forty adult male Sprague-Dawley (SD) rats were randomly divided into 5 groups: Control group (CON), 28 days IHH group (IHH28), 42 days IHH group (IHH42), 28 days CHH group (CHH28) and 42 days CHH group (CHH42). The rats in IHH groups were treated with intermittent hypoxia (11.1% O2) mimicking 5 000 m altitude in a hypobaric chamber for 28 or 42 d, 6 h a day, respectively. The rats in CHH groups lived in the hypobaric chamber with the same degree of hypoxia like IHH rats except half an hour in normoxia each day for feeding and cleaning. The body weight of rats was measured once a week. The parameters in hemodynamics, such as mean artery blood pressure (MAP), heart rate (HR), left ventricular systolic pressure (LVSP), maximum change rate of left ventricular pressure (+/-LVdP/dt(max)) were recorded under basic normoxia and acute hypoxia conditions through catheterization technique. The superoxide dismutase (SOD) activity and malondialdehyde (MDA) content in myocardium of rats were measured by biochemical method. The weights of whole heart, left and right ventricles were measured separately. The results showed: (1) The basic HR and MAP in CHH42 rats were lower than those in CON, IHH and CHH28 rats (P<0.05). (2) IHH showed a cardioprotection against acute hypoxia and reoxygenation injury, manifested as the result that the changes of HR, MAP, LVSP, and +/- LVdP/dt(max) were smaller than those in CON rats during acute hypoxia and reoxygenation. CHH showed a rather strong cardioprotection during acute hypoxia, manifested as the result that the decreases of HR, MAP, LVSP, and +/- LVdP/dt(max)were much smaller, but it did damage during reoxygenation, manifested as the result that the recovery of hemodynamics was the worst among three groups (P<0.05). (3) The antioxygenation of heart was increased in both IHH and CHH rats compared with that in CON rats manifested by the increased SOD activity and decreased MDA content (P<0.05, P<0.01). (4) IHH had no effect on heart weight, but CHH rats showed an obvious right ventricular hypertrophy compared with CON and IHH animals (P<0.01). The result indicates that IHH can induce a more effective cardioprotection with no much side effect, which might have a potential value for practical use.

UI MeSH Term Description Entries
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000531 Altitude A vertical distance measured from a known level on the surface of a planet or other celestial body. Altitudes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D013482 Superoxide Dismutase An oxidoreductase that catalyzes the reaction between SUPEROXIDES and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. Hemocuprein,Ag-Zn Superoxide Dismutase,Cobalt Superoxide Dismutase,Cu-Superoxide Dismutase,Erythrocuprein,Fe-Superoxide Dismutase,Fe-Zn Superoxide Dismutase,Iron Superoxide Dismutase,Manganese Superoxide Dismutase,Mn-SOD,Mn-Superoxide Dismutase,Ag Zn Superoxide Dismutase,Cu Superoxide Dismutase,Dismutase, Ag-Zn Superoxide,Dismutase, Cobalt Superoxide,Dismutase, Cu-Superoxide,Dismutase, Fe-Superoxide,Dismutase, Fe-Zn Superoxide,Dismutase, Iron Superoxide,Dismutase, Manganese Superoxide,Dismutase, Mn-Superoxide,Dismutase, Superoxide,Fe Superoxide Dismutase,Fe Zn Superoxide Dismutase,Mn SOD,Mn Superoxide Dismutase,Superoxide Dismutase, Ag-Zn,Superoxide Dismutase, Cobalt,Superoxide Dismutase, Fe-Zn,Superoxide Dismutase, Iron,Superoxide Dismutase, Manganese
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
April 2004, The Japanese journal of physiology,
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
November 2009, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
May 2022, Molecular medicine reports,
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
June 2011, Sheng li xue bao : [Acta physiologica Sinica],
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
January 2015, Journal of inflammation (London, England),
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
February 2012, The Chinese journal of physiology,
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
January 2020, Clinical and experimental pharmacology & physiology,
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
October 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
November 2012, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Fang Yuan, and Zan Guo, and Ying Xu, and Xin Wang, and Hui-Min Bu, and Ning Zhong, and Yi Zhang, and Zhao-Nian Zhou
September 2016, Life sciences,
Copied contents to your clipboard!